A one-year prospective study of refractory status epilepticus in Modena, Italy

Epilepsy and Behavior

Volumn 49, Issue , 2015, Pages 141-145

  Giovannini, Giada ^a,b   Monti, Giulia ^a,b   Polisi, Michela M ^a,b   Mirandola, Laura ^a,b   Marudi, Andrea ^b   Pinelli, Giovanni ^b   Valzania, Franco ^b   Girardis, Massimo ^c   Nichelli, Paolo F ^a,b   Meletti, Stefano ^a,b  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^b NOCSAE Hospital   (Italy)

^c UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

Disability; Mortality; Predictors; Refractory status epilepticus; Status epilepticus; Super refractory status epilepticus

Indexed keywords

ANESTHETIC AGENT; ANTICONVULSIVE AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL FEATURE; COMA; CONTROLLED STUDY; DISEASE CLASSIFICATION; DISEASE COURSE; EPILEPTIC STATE; FEMALE; HEART DISEASE; HUMAN; ITALY; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MORBIDITY; MORTALITY; OUTCOME ASSESSMENT; PREDICTION; PROSPECTIVE STUDY; RECURRENT DISEASE; REFRACTORY STATUS EPILEPTICUS; RESPIRATORY TRACT DISEASE; STUPOR; FOLLOW UP; INCIDENCE; MIDDLE AGED; PROGNOSIS; STATUS EPILEPTICUS; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTICONVULSANTS; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; ITALY; MALE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; RECURRENCE; STATUS EPILEPTICUS; YOUNG ADULT;

EID: 84938980219     PISSN: 15255050     EISSN: 15255069     Source Type: Journal    
DOI: 10.1016/j.yebeh.2015.05.022     Document Type: Article

References (33)

1. Blume W.T., Lüders H.O., Mizrahi E., Tassinari C., Boas W.E., Engel J. Glossary of descriptive terminology for ictal semiology: report of the ILAE Task Force on Classification and Terminology. Epilepsia 2001, 42(9):1212-1218.
2. Logroscino G., Hesdorffer D.C., Cascino G., Annegers J.F., Hauser W.A. Short-term mortality after a first episode of status epilepticus. Epilepsia 1997, 38:1344-1349.
3. DeLorenzo R.J., Hauser W.A., Towne A.R., Boggs J.G., Pellock J.M., Penberthy L., et al. A prospective, population-based epidemiologic study of status epilepticus in Richmond, Virginia. Neurology 1996, 46:1029-1035.
4. Vignatelli L., Rinaldi R., Galeotti M., De Carolis P., D'Alessandro R. Epidemiology of status epilepticus in a rural area of northern Italy: a 2-year-population-based study. Eur J Neurol 2005, 12:897-902.
5. Vignatelli L., Tonon C., D'Alessandro R. Incidence and short-term prognosis of status epilepticus in adults in Bologna, Italy. Epilepsia 2003, 44(7):964-968. on behalf of the Bologna Group for the Study of Status Epilepticus.
6. Knake S., Rosenow F., Vescovi M., Oertel W.H., Mueller H.-H., Wirbatz A., et al. Incidence of status epilepticus in adults in Germany: a prospective, population-based study. Epilepsia 2001, 42:714-718.
7. Jallon P., Coeytaux A., Galobardes B., Morabia A. Incidence and case-fatality rate of status epilepticus in the Canton of Geneva. Lancet 1999, 353:1496.
8. Coeytaux A., Jallon P., Galobardes B., Morabia A. Incidence of status epilepticus in French-speaking Switzerland (EPISTAR). Neurology 2000, 55:693-697.
9. Logroscino G., Hesdorffer D.C., Cascino G., Hauser W.A., Coeytaux A., Galobardes B., et al. Mortality after a first episode of status epilepticus in the United States and Europe. Epilepsia 2005, 46(11):46-48.
10. Hesdorffer D.C., Logroscino G., Cascino G., Annegers J.F., Hauser W.A. Incidence of status epilepticus in Rochester, Minnesota, 1965-1984. Neurology 1998, 50:735-741.
11. Prasad A., Worral B.B., Bertram E.H., Bleck T.P. Propofol and midazolam in the treatment of refractory status epilepticus. Epilepsia 2001, 42(3):380-386.
12. Mayer S.A., Claassen J., Lokin J., Mendelsohn F., Dennis L.J., Fitzsimmons B.F. Refractory status epilepticus: frequency, risk factors, and impact on outcome. Arch Neurol 2002, 59(2):205-210.
13. Tripathi M., Vibha D., Choudhary N., Prasad K., Srivastava P., Bhatia R., et al. Management of refractory status epilepticus at a tertiary care centre in a developing country. Seizure 2010, 19:109-111.
14. Hocker S.E., Britton J.W., Mandrekar J.N., Wijdicks E.F.M., Rabinstein A.A. Predictors of outcomes in refractory status epilepticus. JAMA Neurol 2013, 70(1):72-77.
15. Sutter R., Marsch S., Fuhr P., Rüegg S. Mortality and recovery from refractory status epilepticus in the intensive care unit: a 7-year observational study. Epilepsia 2013, 54(3):502-511.
16. Novy J., Logroscino G., Rossetti A.O. Refractory status epilepticus: a prospective observational study. Epilepsia 2010, 51(2):251-256.
17. Holtkamp M., Othman J., Buchheim K., Meierkord H. Predictor and prognosis of refractory status epilepticus treated in a neurological intensive care unit. J Neurol Neurosurg Psychiatry 2005, 76:534-539.
18. Rossetti A.O., Logroscino G., Bromfield E.B. Refractory status epilepticus: effect of treatment aggressiveness on prognosis. Arch Neurol 2005, 62(11):1698-1702.
19. Liberalesso P.B.N., Garzon E., Yacubian E.M.T., Sakamoto A.C. Higher mortality rate associated with advanced age and periodic lateralized epileptiform discharges in patients with refractory status epilepticus. Arq Neuropsiquiatr 2013, 71(3):153-158.
20. Rossetti A.O., Logroscino G., Milligan T.A., Michaelides C., Ruffieux C., Bromfield E.B. Status Epilepticus Severity Score (STESS): a tool to orient early treatment strategy. J Neurol 2008, 255:1561-1566.
21. Agan K., Afsar N., Midi I., Us O., Aktan S., Ayukut-Bingol C. Predictors of refractoriness in a Turkish status epilepticus data bank. Epilepsy Behav 2009, 14:651-654.
22. Sutter R., Kaplan P.W., Marsch S., Hammel S., Hammel E.M., Rüegg S., et al. Early predictors of refractory status epilepticus: an international two-center study. Eur J Neurol 2015, 22(1):79-85.
23. Vooturi S., Jayalakshmi S., Sahu S., Mohandas S. Prognosis and predictors of outcome of refractory generalized convulsive status epilepticus in adults treated in neurointensive care unit. Clin Neurol Neurosurg 2014, 126:7-10.
24. Drislane F.W., Blum A.S., Lopez M.R., Gautam S., Schomer D.L. Duration of refractory status epilepticus and outcome: loss of prognostic utility after several hours. Epilepsia 2009, 50(6):1566-1571.
25. Jayalakshmi S., Ruikar D., Vooturi S., Alladi S., Sahu S., Kaul S., et al. Determinants and predictors of outcome in super-refractory status epilepticus - a developing country perspective. Epilepsy Res 2014, 108:1609-1617.
26. Claassen J., Hirsch L.J., Emerson R.G., Mayer S.A. Treatment of refractory status epilepticus with pentobarbital, propofol or midazolam: a systematic review. Epilepsia 2002, 43(2):146-153.
27. Lowenstein D.H., Bleck T., Macdonald R.L. It's time to revise the definition of status epilepticus. Epilepsia 1999, 40:120-122.
28. Shorvon S., Ferlisi M. The treatment of super-refractory status epilepticus: a critical review of available therapies and a clinical treatment protocol. Brain 2011, 134:2802-2818.
29. Guidelines for epidemiologic studies on epilepsy. Commission on Epidemiology and Prognosis, International League Against Epilepsy. Epilepsia 1993, 34(4):592-596.
30. Rossetti A.O., Hurwitz S., Logroscino G., Bromfield E.B. Prognosis of status epilepticus: role of aetiology, age and consciousness impairment at presentation. J Neurol Neurosurg Psychiatry 2006, 77:611-615.
31. Rossetti A.O., Logroscino G., Bromfield E.B. A clinical score for prognosis of status epilepticus in adults. Neurology 2006, 66(11):1736-1738.
32. Tian L., Li Y., Xue X., Wu M., Liu F., Hao X., et al. Super-refractory status epilepticus in West China. Acta Neurol Scand 2014, 10.1111/ane.12336.
33. Leitinger Höller Y., Kalss G., Rohracher A., Novak H.F., Höfler J., Dobesberger J., et al. Epidemiology-based mortality score in status epilepticus (EMSE). Neurocrit Care 2015, 22:273-282.